Cumberland Pharmaceuticals (CPIX) Stock Statistics & Valuation Metrics

Cumberland Pharmaceuticals has a market cap or net worth of $62.86M. The enterprise value is $35.41M.

Cumberland Pharmaceuticals has 13,968,394 shares outstanding. The number of shares has decreased by -2.65% in one year.

Cumberland Pharmaceuticals’s return on equity (ROE) is >-0.01 and return on invested capital (ROIC) is >-0.01%.

The current PE Ratio of Cumberland Pharmaceuticals is -5.14. Cumberland Pharmaceuticals’s PEG ratio is -1.13.

In the last 12 months, Cumberland Pharmaceuticals had revenue of 37.87M and earned -6.48M in profits. Earnings per share was -0.46.

In the last 12 months, operating cash flow was -612.19K and capital expenditures -90.99K, giving a free cash flow of -703.17K billion.

Cumberland Pharmaceuticals pays an annual dividend of ―, resulting in a dividend yield of ―

Cumberland Pharmaceuticals upcoming earnings date is Aug 12, 2025, TBA Not Confirmed.

Cumberland Pharmaceuticals as a current ratio of 1.15, with Debt / Equity ratio of 90.02%

In the past 12 months, Cumberland Pharmaceuticals has paid -22.67K in taxes.

Cumberland Pharmaceuticals EV to EBITDA ratio is -405.49K, with an EV/FCF ratio of -3.84.

Cumberland Pharmaceuticals has $17.96M in cash and marketable securities with ― in debt, giving a net cash position of $2.61M billion.

Gross margin is 76.56%, with operating margin of -16.99%, and net profit margin of -17.11%.

The average price target for Cumberland Pharmaceuticals is ―, which is 11.43% higher than the current price. The consensus rating is ―